Personal opinion? The numbers (lower stock price) don't lie. That is a fact. Zero for three on 2017 trial starts is a fact, not an opinion.
Here IS my personal opinion: Missling is not starting the trials because he has that sinking feeling that his wonder drug isn't going to be efficacious. Perhaps the analysis he has gotten thus far is not showing any significant statistical correlation. The solution to this potential dilemma: If you don't start the trials, they cannot fail.
I sure hope that I'm wrong (for my financial well being, as well as the hope a wonder drug may provide people afflicted with these CNS disorders).
Putting out "cream puff fluff" PRs about a trial from 2 1/2 years ago does nothing to bolster my confidence, nor that of several members on this board.
Yes, I am a disillusioned investor in this company. I can't imagine there are too many institutional investors who are pleased with Dr. M as of right now (unless they are short sellers). If more lose hope and faith in the company (and perhaps some already have), this will put further downward pressure on the stock.
God help us.
News 
Market Data 
Discover 
